Browse studies

Find your next paid study

1 recruiting study matching your filters

LINNOVATE: A Phase 1/2 Study of Safety/Efficacy Using LURBINECTEDIN, Combined With IPILIMUMAB, and NIVOLUMAB for Advanced Soft Tissue Sarcomas

This is an open label, dose-seeking phase 1/2 study using escalating doses of LURBINECTEDIN administered intravenously with fixed doses of IPILIMUMAB and NIVOL…

Advanced Soft-tissue Sarcoma

ERLINDA M GORDONNCT05876715